Julie A. Margenthaler

9.2k total citations
203 papers, 5.5k citations indexed

About

Julie A. Margenthaler is a scholar working on Cancer Research, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Julie A. Margenthaler has authored 203 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Cancer Research, 77 papers in Surgery and 68 papers in Pathology and Forensic Medicine. Recurrent topics in Julie A. Margenthaler's work include Breast Cancer Treatment Studies (113 papers), Breast Lesions and Carcinomas (65 papers) and Breast Implant and Reconstruction (58 papers). Julie A. Margenthaler is often cited by papers focused on Breast Cancer Treatment Studies (113 papers), Breast Lesions and Carcinomas (65 papers) and Breast Implant and Reconstruction (58 papers). Julie A. Margenthaler collaborates with scholars based in United States, Australia and Nigeria. Julie A. Margenthaler's co-authors include Feng Gao, Donna B. Jeffe, Rebecca Aft, William E. Gillanders, Timothy J. Eberlein, Anjali D. Deshpande, Jennifer L. Gnerlich, Lihong V. Wang, Amy Cyr and Jill R. Dietz and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Julie A. Margenthaler

190 papers receiving 5.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julie A. Margenthaler United States 41 2.4k 1.8k 1.7k 1.2k 803 203 5.5k
Lee G. Wilke United States 29 2.2k 0.9× 1.5k 0.8× 1.4k 0.8× 1.4k 1.1× 392 0.5× 103 4.0k
Helena M. Verkooijen Netherlands 51 2.5k 1.1× 3.4k 1.9× 1.9k 1.1× 1.9k 1.5× 502 0.6× 327 8.5k
Michele A. Gadd United States 44 3.6k 1.5× 2.4k 1.3× 2.4k 1.5× 2.4k 1.9× 244 0.3× 131 6.8k
Michelle C. Specht United States 43 2.6k 1.1× 1.9k 1.1× 2.2k 1.3× 1.3k 1.1× 209 0.3× 144 5.2k
Richard J. Gray United States 44 2.1k 0.9× 1.7k 1.0× 2.5k 1.5× 1.5k 1.3× 201 0.3× 171 6.0k
Carien L. Creutzberg Netherlands 61 1.9k 0.8× 2.9k 1.6× 2.3k 1.4× 1.5k 1.2× 333 0.4× 208 15.5k
Christof Sohn Germany 46 2.5k 1.0× 2.3k 1.2× 975 0.6× 906 0.7× 348 0.4× 303 7.7k
Frances C. Wright Canada 35 1.3k 0.6× 2.1k 1.2× 1.2k 0.7× 916 0.7× 306 0.4× 234 5.0k
Mehra Golshan United States 41 3.9k 1.6× 3.2k 1.7× 1.5k 0.9× 1.9k 1.6× 160 0.2× 176 6.3k
Sushil Beriwal United States 40 1.3k 0.6× 2.0k 1.1× 2.7k 1.6× 818 0.7× 272 0.3× 405 8.2k

Countries citing papers authored by Julie A. Margenthaler

Since Specialization
Citations

This map shows the geographic impact of Julie A. Margenthaler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie A. Margenthaler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie A. Margenthaler more than expected).

Fields of papers citing papers by Julie A. Margenthaler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie A. Margenthaler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie A. Margenthaler. The network helps show where Julie A. Margenthaler may publish in the future.

Co-authorship network of co-authors of Julie A. Margenthaler

This figure shows the co-authorship network connecting the top 25 collaborators of Julie A. Margenthaler. A scholar is included among the top collaborators of Julie A. Margenthaler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie A. Margenthaler. Julie A. Margenthaler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Pérez, Maria, Donna B. Jeffe, Matthew W. Kreuter, et al.. (2022). Factors associated with initiation and continuation of endocrine therapy in women with hormone receptor-positive breast cancer. BMC Cancer. 22(1). 837–837. 2 indexed citations
4.
Rudra, Soumon, Amit Roy, Randall Brenneman, et al.. (2020). Radiation-Induced Brachial Plexopathy in Patients With Breast Cancer Treated With Comprehensive Adjuvant Radiation Therapy. Advances in Radiation Oncology. 6(1). 100602–100602. 11 indexed citations
5.
Jonczyk, Michael M., Carla S. Fisher, Jessica K. Paulus, et al.. (2020). Surgical Predictive Model for Breast Cancer Patients Assessing Acute Postoperative Complications: The Breast Cancer Surgery Risk Calculator (BCSRc). Journal of the American College of Surgeons. 231(4). S43–S43. 1 indexed citations
6.
Schootman, Mario, Maria Pérez, Qiang Fu, et al.. (2020). Influence of built environment on quality of life changes in African-American patients with non-metastatic breast cancer. Health & Place. 63. 102333–102333. 11 indexed citations
7.
Yu, Jennifer S., Leisha C. Elmore, Amy Cyr, et al.. (2017). Cost Analysis of a Surgical Consensus Guideline in Breast-Conserving Surgery. Journal of the American College of Surgeons. 225(2). 294–301. 18 indexed citations
8.
Cyr, Amy, Foluso O. Ademuyiwa, Adel Tabchy, et al.. (2016). Axillary Ultrasound Accurately Excludes Clinically Significant Lymph Node Disease in Patients With Early Stage Breast Cancer. Annals of Surgery. 264(6). 1098–1102. 48 indexed citations
9.
Margenthaler, Julie A., et al.. (2015). Staging studies have limited utility for newly diagnosed stage I–II breast cancer. Journal of Surgical Research. 196(1). 33–38. 15 indexed citations
10.
Yan, Yan, et al.. (2015). Predictors of false negative axillary ultrasound in breast cancer. Journal of Surgical Research. 198(2). 351–354. 12 indexed citations
11.
Fayanju, Oluwadamilola M., et al.. (2014). Breast cancer patients' experiences within and outside the safety net. Journal of Surgical Research. 190(1). 126–133. 4 indexed citations
12.
Fisher, Carla S., V. Suzanne Klimberg, Seema A. Khan, Feng Gao, & Julie A. Margenthaler. (2011). Margin Index Is Not a Reliable Tool for Predicting Residual Disease after Breast-Conserving Surgery for DCIS. Annals of Surgical Oncology. 18(11). 3155–3159. 8 indexed citations
13.
Fisher, Carla S., X. Cynthia, William E. Gillanders, et al.. (2011). Neoadjuvant Chemotherapy Is Associated with Improved Survival Compared with Adjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer Only after Complete Pathologic Response. Annals of Surgical Oncology. 19(1). 253–258. 54 indexed citations
14.
Cyr, Amy, William E. Gillanders, Rebecca Aft, Timothy J. Eberlein, & Julie A. Margenthaler. (2010). Breast cancer in elderly women (≥80 years): variation in standard of care?. Journal of Surgical Oncology. 103(3). 201–206. 35 indexed citations
15.
Bharat, Ankit, Feng Gao, & Julie A. Margenthaler. (2009). Tumor characteristics and patient outcomes are similar between invasive lobular and mixed invasive ductal/lobular breast cancers but differ from pure invasive ductal breast cancers. The American Journal of Surgery. 198(4). 516–519. 59 indexed citations
16.
Song, Kwang Yong, Erich W. Stein, Julie A. Margenthaler, & Lihong V. Wang. (2008). Noninvasive photoacoustic identification of sentinel lymph nodes containing methylene blue in vivo in a rat model. Journal of Biomedical Optics. 13(5). 54033–54033. 180 indexed citations
17.
Gnerlich, Jennifer L., Jeffrey Dueker, Donna B. Jeffe, et al.. (2008). Patient and Tumor Characteristics Associated with Primary Tumor Resection in Women with Stage IV Breast Cancer: Analysis of 1988-2003 SEER Data. The Breast Journal. 14(6). 538–542. 10 indexed citations
18.
Kataoka, Masaaki, Julie A. Margenthaler, Grace Ku, & M. Wayne Flye. (2003). Development of Infectious Tolerance After Donor-Specific Transfusion and Rat Heart Transplantation. The Journal of Immunology. 171(1). 204–211. 24 indexed citations
19.
Margenthaler, Julie A., Masaaki Kataoka, & M. Wayne Flye. (2003). Peripheral tolerance in transgenic mice expressing class I MHC Ld only on cardiac cells. Transplant Immunology. 12(2). 133–141.
20.
Margenthaler, Julie A., et al.. (2002). CD1-Dependent Natural Killer (NK1.1+) T Cells Are Required for Oral and Portal Venous Tolerance Induction. Journal of Surgical Research. 104(1). 29–35. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lee G. Wilke Breakdown of academic impact, for papers by Helena M. Verkooijen Breakdown of academic impact, for papers by Michele A. Gadd Breakdown of academic impact, for papers by Michelle C. Specht Breakdown of academic impact, for papers by Richard J. Gray Breakdown of academic impact, for papers by Carien L. Creutzberg Breakdown of academic impact, for papers by Christof Sohn Breakdown of academic impact, for papers by Frances C. Wright Breakdown of academic impact, for papers by Mehra Golshan Breakdown of academic impact, for papers by Sushil Beriwal
Rankless by CCL
2026